Applied Optoelectronics Reports Fourth Quarter and Year 2016 Results
Feb 23, 2017 21:03 pm UTC| Business
SUGAR LAND, Texas, Feb. 23, 2017 -- Applied Optoelectronics, Inc. (NASDAQ:AAOI), a leading provider of fiber-optic network products for the internet datacenter, cable broadband, fiber-to-the-home and telecom markets,...
BJ’s Restaurants, Inc. Reports Fourth Quarter and Fiscal 2016 Results
Feb 23, 2017 21:03 pm UTC| Business
HUNTINGTON BEACH, Calif., Feb. 23, 2017 -- BJ’s Restaurants, Inc. (NASDAQ:BJRI) today reported financial results for its fourth quarter and fiscal year ended Tuesday,January 3, 2017. The results for thefourthquarter and...
Impac Mortgage Holdings, Inc. Announces Fourth Quarter and Year End 2016 Results
Feb 23, 2017 21:03 pm UTC| Business
IRVINE, Calif., Feb. 23, 2017 -- Impac Mortgage Holdings, Inc. (NYSE MKT:IMH) announces the financial results for the fourth quarter and year ended December 31, 2016. For the year ended 2016, the Company reported GAAP...
Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call
Feb 23, 2017 21:02 pm UTC| Business
ROCKVILLE, Md., Feb. 23, 2017 -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its fourth quarter and full year 2016 financial results...
Galapagos reports strong financial results and newsflow-rich pipeline
Feb 23, 2017 21:02 pm UTC| Business
Key 2016 results: Group revenues increased by €91.0 million to €151.6 million Operating loss reduced by €77.9 million to €11.5 million Net profit of €54.0 million, compared to a net loss of €118.4 million in...
Galapagos reports strong financial results and newsflow-rich pipeline
Feb 23, 2017 21:02 pm UTC| Business
Key 2016 results: Group revenues increased by €91.0 million to €151.6 million Operating loss reduced by €77.9 million to €11.5 million Net profit of €54.0 million, compared to a net loss of €118.4 million in...
Achaogen Announces Leadership Promotions
Feb 23, 2017 21:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2017 -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company discovering and developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative...